Table 2. Effects of AeSCP-2 siRNA expression on development.
| batch | 3rd day | 7th day | 11th day | Total mortality | ||||||||||
| 3rd | 4th | dead | 4th | pupa | dead | 4th | pupa | adult | dead | larvae | P+ early A | total | ||
| Control, started at 2nd instar (N = 30/batch) | #1 | 7 | 20 | 3 | 3 | 21 | 3 | 0 | 0 | 20 | 4 | 20% (6)* | 17% (4) | 27% |
| #2 | 5 | 22 | 3 | 8 | 17 | 3 | 0 | 2 | 19 | 7 | 30% (9) | 5% (1) | 35% | |
| #3 | 8 | 19 | 3 | 7 | 20 | 2 | 0 | 0 | 22 | 4 | 27% (8) | 9% (2) | 36% | |
| #4 | 5 | 22 | 3 | 3 | 23 | 1 | 0 | 0 | 23 | 3 | 17% (5) | 8% (2) | 25% | |
| Induced siRNA at 2nd instar (N = 30/batch) | #1 | 26 | 1 | 3 | 10 | 13 | 4 | 3 | 5 | 11 | 5 | 30% (9) | 29% (6) | 59% |
| #2 | 23 | 2 | 5 | 17 | 2 | 6 | 0 | 8 | 10 | 1 | 40% (12) | 6% (1) | 46% | |
| #3 | 22 | 3 | 5 | 17 | 3 | 5 | 0 | 6 | 12 | 2 | 40% (12) | 6% (1) | 46% | |
| #4 | 22 | 2 | 6 | 18 | 2 | 4 | 2 | 5 | 11 | 2 | 40% (12) | 6% (0) | 40% | |
*Number in () indicates the actual number of fatality in the cohort.